108 related articles for article (PubMed ID: 18579388)
1. Illudalic acid as a potential LAR inhibitor: synthesis, SAR, and preliminary studies on the mechanism of action.
Ling Q; Huang Y; Zhou Y; Cai Z; Xiong B; Zhang Y; Ma L; Wang X; Li X; Li J; Shen J
Bioorg Med Chem; 2008 Aug; 16(15):7399-409. PubMed ID: 18579388
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid.
Ling Q; Zhou YY; Cai ZL; Zhang YH; Xiong B; Ma LP; Wang X; Li X; Li J; Shen JK
Yao Xue Xue Bao; 2010 Nov; 45(11):1385-97. PubMed ID: 21355526
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and PTP Inhibitory Activity of Illudalic Acid and Its Methyl Ether, with Insights into Selectivity for LAR PTP over Other Tyrosine Phosphatases under Physiologically Relevant Conditions.
McCullough BS; Batsomboon P; Hutchinson KB; Dudley GB; Barrios AM
J Nat Prod; 2019 Dec; 82(12):3386-3393. PubMed ID: 31809044
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of covalent inhibition of LAR phosphatase by illudalic acid.
Hansen DT; Rueb NJ; Levinzon ND; Cheatham TE; Gaston R; Tanvir Ahmed K; Osburn-Staker S; Cox JE; Dudley GB; Barrios AM
Bioorg Med Chem Lett; 2024 May; 104():129740. PubMed ID: 38599294
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of illudalic acid and analogous phosphatase inhibitors.
Fulo HF; Rueb NJ; Gaston R; Batsomboon P; Ahmed KT; Barrios AM; Dudley GB
Org Biomol Chem; 2021 Dec; 19(48):10596-10600. PubMed ID: 34847212
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development.
Henderson IM; Zeng F; Bhuiyan NH; Luo D; Martinez M; Smoake J; Bi F; Perera C; Johnson D; Prisinzano TE; Wang W; Uhl GR
Biochem Pharmacol; 2022 Jan; 195():114868. PubMed ID: 34863978
[TBL] [Abstract][Full Text] [Related]
7. Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.
Salar U; Khan KM; Iqbal J; Ejaz SA; Hameed A; Al-Rashida M; Perveen S; Tahir MN
Eur J Med Chem; 2017 May; 131():29-47. PubMed ID: 28288318
[TBL] [Abstract][Full Text] [Related]
8. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
Thakur A; Singla R; Jaitak V
Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
[TBL] [Abstract][Full Text] [Related]
9. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity.
Roussaki M; Kontogiorgis CA; Hadjipavlou-Litina D; Hamilakis S; Detsi A
Bioorg Med Chem Lett; 2010 Jul; 20(13):3889-92. PubMed ID: 20627725
[TBL] [Abstract][Full Text] [Related]
10. Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors.
Shen Q; Shao J; Peng Q; Zhang W; Ma L; Chan AS; Gu L
J Med Chem; 2010 Dec; 53(23):8252-9. PubMed ID: 21053896
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.
Zhou X; Wang XB; Wang T; Kong LY
Bioorg Med Chem; 2008 Sep; 16(17):8011-21. PubMed ID: 18701305
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, cytotoxicity and SAR of simple geiparvarin analogues.
Valenti P; Rampa A; Recanatini M; Bisi A; Belluti F; Da Re P; Carrara M; Cima L
Anticancer Drug Des; 1997 Sep; 12(6):443-51. PubMed ID: 9311554
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
[TBL] [Abstract][Full Text] [Related]
14. Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach.
Wu JW; Zhang H; Li WY; Tang X; Li HL; Lu XH; Zheng ZH; Ma Y; Wang RL
J Biomol Struct Dyn; 2020 Nov; 38(18):5338-5348. PubMed ID: 31787068
[TBL] [Abstract][Full Text] [Related]
15. The characterisation of coumarins from selected structural classes by electrospray ionisation quadrupole time-of-flight tandem mass spectrometry.
Smyth WF; Morgan JL; O'Kane E; Millar TJ; Ramachandran VN
Rapid Commun Mass Spectrom; 2011 May; 25(9):1308-14. PubMed ID: 21491531
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
17. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.
Kawate T; Iwase N; Shimizu M; Stanley SA; Wellington S; Kazyanskaya E; Hung DT
Bioorg Med Chem Lett; 2013 Nov; 23(22):6052-9. PubMed ID: 24103299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
